The Event

Women in venture Capital Summit:Europe

Related News

Women in venture Capital Summit:Europe

26 – 27 September 2022,

Minoryx‘s Marketing Authorization Application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked Adrenoleukodystrophy (X-ALD)

The EMA has now validated the MAA file and it is under review by the Committee for Medicinal Products for Human Use (CHMP).

SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases

Proceeds to fund first-in-human trials of breakthrough gene therapy products and advance CRISPR-based genome editing portfolio.